vs

Side-by-side financial comparison of Infobird Co., Ltd (IFBD) and MESOBLAST LTD (MESO). Click either name above to swap in a different company.

Infobird Co., Ltd is the larger business by last-quarter revenue ($3.4M vs $1.9M, roughly 1.8× MESOBLAST LTD). Infobird Co., Ltd runs the higher net margin — -46.7% vs -959.3%, a 912.5% gap on every dollar of revenue. On growth, Infobird Co., Ltd posted the faster year-over-year revenue change (17118.0% vs -3.6%).

Infobird Co., Ltd. is a China-based technology firm specializing in AI-powered customer engagement and smart customer service solutions. It serves clients across e-commerce, finance, telecommunications, and internet service sectors, offering cloud-based SaaS tools, intelligent call center systems, and customized digital operation support to help enterprises boost service efficiency and customer satisfaction.

Mesoblast Limited is an Australian regenerative medicine company. It seeks to provide treatments for inflammatory ailments, cardiovascular disease, and back pain. The company is led by Silviu Itescu, who founded the company in 2004.

IFBD vs MESO — Head-to-Head

Bigger by revenue
IFBD
IFBD
1.8× larger
IFBD
$3.4M
$1.9M
MESO
Growing faster (revenue YoY)
IFBD
IFBD
+17121.6% gap
IFBD
17118.0%
-3.6%
MESO
Higher net margin
IFBD
IFBD
912.5% more per $
IFBD
-46.7%
-959.3%
MESO

Income Statement — Q2 FY2025 vs Q3 FY2023

Metric
IFBD
IFBD
MESO
MESO
Revenue
$3.4M
$1.9M
Net Profit
$-1.6M
$-18.6M
Gross Margin
37.2%
Operating Margin
-31.8%
Net Margin
-46.7%
-959.3%
Revenue YoY
17118.0%
-3.6%
Net Profit YoY
-98.1%
12.7%
EPS (diluted)
$-0.41
$-0.03

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IFBD
IFBD
MESO
MESO
Q2 25
$3.4M
Q1 23
$1.9M
Q4 22
$2.1M
Q3 22
$1.5M
Q1 22
$2.0M
Q4 21
$2.4M
Q3 21
$3.6M
Net Profit
IFBD
IFBD
MESO
MESO
Q2 25
$-1.6M
Q1 23
$-18.6M
Q4 22
$-24.5M
Q3 22
$-16.9M
Q1 22
$-21.3M
Q4 21
$-25.9M
Q3 21
$-22.6M
Gross Margin
IFBD
IFBD
MESO
MESO
Q2 25
37.2%
Q1 23
Q4 22
Q3 22
Q1 22
Q4 21
Q3 21
Operating Margin
IFBD
IFBD
MESO
MESO
Q2 25
-31.8%
Q1 23
Q4 22
Q3 22
Q1 22
Q4 21
Q3 21
Net Margin
IFBD
IFBD
MESO
MESO
Q2 25
-46.7%
Q1 23
-959.3%
Q4 22
-1147.4%
Q3 22
-1123.4%
Q1 22
-1059.3%
Q4 21
-1088.8%
Q3 21
-630.1%
EPS (diluted)
IFBD
IFBD
MESO
MESO
Q2 25
$-0.41
Q1 23
$-0.03
Q4 22
$-0.03
Q3 22
$-0.02
Q1 22
$-0.03
Q4 21
$-0.04
Q3 21
$-0.03

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IFBD
IFBD
MESO
MESO
Cash + ST InvestmentsLiquidity on hand
$698.0K
$48.8M
Total DebtLower is stronger
Stockholders' EquityBook value
$66.7M
$482.2M
Total Assets
$72.4M
$650.4M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IFBD
IFBD
MESO
MESO
Q2 25
$698.0K
Q1 23
$48.8M
Q4 22
$67.6M
Q3 22
$85.5M
Q1 22
$76.8M
Q4 21
$94.8M
Q3 21
$116.0M
Stockholders' Equity
IFBD
IFBD
MESO
MESO
Q2 25
$66.7M
Q1 23
$482.2M
Q4 22
$500.0M
Q3 22
$522.8M
Q1 22
$517.1M
Q4 21
$535.5M
Q3 21
$559.7M
Total Assets
IFBD
IFBD
MESO
MESO
Q2 25
$72.4M
Q1 23
$650.4M
Q4 22
$668.1M
Q3 22
$684.5M
Q1 22
$681.7M
Q4 21
$704.4M
Q3 21
$721.8M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IFBD
IFBD
MESO
MESO
Operating Cash FlowLast quarter
$1.1M
$-16.3M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IFBD
IFBD
MESO
MESO
Q2 25
$1.1M
Q1 23
$-16.3M
Q4 22
$-16.5M
Q3 22
$-14.3M
Q1 22
$-15.5M
Q4 21
$-18.2M
Q3 21
$-18.2M

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons